Label Image (Lbl500903145)
This is not available.*
Rabeprazole Sodium
Product Images NDC 50090-3145
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Rabeprazole Sodium (NDC 50090-3145). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Rabeprazole Sodium Delayed Release Tablets 1)
Figure 2 (Rabeprazole Sodium Delayed Release Tablets 2)
The text provides data from a study with three groups of participants - Placebo (n = 68), RAB 10mg (n = 64), and RAB 20mg (n = 67). The study was conducted for a period of 21 days and heartburn scores were recorded on a scale of 0 to 4.*
Figure 3 (Rabeprazole Sodium Delayed Release Tablets 3)
This is a table showing the number of participants in three different treatment groups: Placebo (n=68), RAB 10mg (n=64), and RAB 20mg (n=67).*
Figure 4 (Rabeprazole Sodium Delayed Release Tablets 4)
Figure 5 (Rabeprazole Sodium Delayed Release Tablets 5)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
